PetMed Express
PETS
130 hedge funds and large institutions have $187M invested in PetMed Express in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 46 reducing their positions, and 26 closing their positions.
2% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 46
8% less funds holding
Funds holding: 141 → 130 (-11)
25% less capital invested
Capital invested by funds: $250M → $187M (-$63.3M)
38% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 26
87% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $9.39M
Top Buyers
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$13.7M |
| 2 |
RA
Royce & Associates
New York
|
+$2.92M |
| 3 |
CEI
Clark Estates Inc
New York
|
+$2.11M |
| 4 |
OCMI
Oaktop Capital Management II
Chatham,
New Jersey
|
+$1.68M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.15M |
Top Sellers
PETS Hedge Fund Activity: Q1 2014 in Review
130 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q1 2014, worth a combined $187M — down 25% from $250M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of PETS and 16 opened new positions — a net loss of 10 holders — while 46 trimmed existing stakes and 47 added.
The largest buyer was Allianz Asset Management, adding an estimated $13.7M. The largest seller was Hancock Whitney, exiting entirely with an estimated $6.65M sold.
- 130 institutional investors held PetMed Express (PETS) as of Q1 2014, down from 141 in Q4 2013.
- Funds reported $187M of PetMed Express stock for Q1 2014, down 25% quarter-over-quarter.
- 16 funds opened new PetMed Express positions in Q1 2014 and 26 closed out, a net change of -10 holders.
- The largest PetMed Express buyer in Q1 2014 was Allianz Asset Management, an estimated $13.7M added.
- The largest PetMed Express seller in Q1 2014 was Hancock Whitney, an estimated $6.65M sold.
Based on aggregated 13F filings for Q1 2014.